Q8 hydrochloride
Q8 is a novel cysteinyl leukotreine receptor antagonist, inhibiting VEGF-independent angiogenesis and exerting an additive anti-angiogenic response with bevacizumab.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1642 |
| CAS # | 1541762-55-3 (HCl) |
| Pricing | Customizable size, Inquiry |
| Synonym | Q8; Q8 hydrochloride |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C17H14ClNO2 |
| Exact Mass | 299.0713 |
| Molecular Weight | 299.754 |
| Elemental Analysis | C, 68.12; H, 4.71; Cl, 11.83; N, 4.67; O, 10.67 |
| IUPAC/Chemical Name | (E)-2-(2-Quinolin-2-yl-vinyl)-benzene-1,4-diol Hydrochloride |
| InChi Key | LNPCQDLAMXHIFY-WVLIHFOGSA-N |
| InChi Code | InChI=1S/C17H13NO2.ClH/c19-15-9-10-17(20)13(11-15)6-8-14-7-5-12-3-1-2-4-16(12)18-14;/h1-11,19-20H;1H/b8-6+; |
| SMILES Code | OC1=CC=C(O)C=C1/C=C/C2=NC3=CC=CC=C3C=C2.[H]Cl |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |